tiprankstipranks
Shanghai Bio-Heart Biological Technology Co., Ltd. Class H (HK:2185)
:2185
Hong Kong Market
2185
Shanghai Bio-Heart Biological Technology Co., Ltd. Class H
RESEARCH TOOLSreports
Want to see HK:2185 full AI Analyst Report?

Shanghai Bio-Heart Biological Technology Co., Ltd. Class H (2185) Ratios

0 Followers

Shanghai Bio-Heart Biological Technology Co., Ltd. Class H Ratios

HK:2185's free cash flow for Q4 2025 was ¥-0.09. For the 2025 fiscal year, HK:2185's free cash flow was decreased by ¥ and operating cash flow was ¥-2.10. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 15.26 15.26 15.22 20.35 16.72
Quick Ratio
 13.77 13.77 13.81 20.16 16.72
Cash Ratio
 3.69 3.69 10.30 18.41 15.65
Solvency Ratio
 -0.25 -0.23 -1.34 -4.04 -3.35
Operating Cash Flow Ratio
 -2.31 -2.61 -6.08 -2.44 -4.34
Short-Term Operating Cash Flow Coverage
 -25.78 -29.14 0.00 0.00 0.00
Net Current Asset Value
¥ 161.60M¥ 161.60M¥ 245.78M¥ 364.43M¥ 475.06M
Leverage Ratios
Debt-to-Assets Ratio
 0.02 0.02 0.01 <0.01 0.02
Debt-to-Equity Ratio
 0.03 0.03 0.01 <0.01 0.02
Debt-to-Capital Ratio
 0.03 0.03 0.01 <0.01 0.02
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.91 1.91 1.11 1.09 1.11
Debt Service Coverage Ratio
 -4.47 -2.35 0.00 -266.01 -216.92
Interest Coverage Ratio
 -14.80 -8.20 0.00 -284.82 -305.82
Debt to Market Cap
 <0.01 <0.01 0.00 0.00 0.00
Interest Debt Per Share
 0.07 0.09 0.03 <0.01 0.08
Net Debt to EBITDA
 1.39 1.53 4.36 2.48 2.06
Profitability Margins
Gross Profit Margin
17.17%-0.36%0.00%0.00%0.00%
EBIT Margin
-159.11%-159.56%0.00%0.00%0.00%
EBITDA Margin
-128.50%-119.10%0.00%0.00%0.00%
Operating Profit Margin
-159.11%-159.56%0.00%0.00%0.00%
Pretax Profit Margin
-213.02%-213.66%0.00%0.00%0.00%
Net Profit Margin
-155.71%-155.91%0.00%0.00%0.00%
Continuous Operations Profit Margin
-155.20%-152.31%0.00%0.00%0.00%
Net Income Per EBT
73.10%72.97%94.24%102.93%89.02%
EBT Per EBIT
133.89%133.91%152.89%114.70%90.97%
Return on Assets (ROA)
-8.33%-8.19%-11.99%-23.76%-24.20%
Return on Equity (ROE)
-15.19%-15.69%-13.32%-25.97%-26.89%
Return on Capital Employed (ROCE)
-8.77%-8.65%-8.55%-20.63%-30.90%
Return on Invested Capital (ROIC)
-6.37%-6.15%-8.53%-20.59%-25.83%
Return on Tangible Assets
-12.34%-12.14%-19.48%-36.29%-33.96%
Earnings Yield
-9.20%-5.39%-23.46%-25.77%-18.92%
Efficiency Ratios
Receivables Turnover
 2.05 2.02 0.00 0.00 0.00
Payables Turnover
 16.62 19.79 0.00 0.00 0.00
Inventory Turnover
 0.99 1.18 0.00 5.93 0.00
Fixed Asset Turnover
 0.53 0.52 0.00 0.00 0.00
Asset Turnover
 0.05 0.05 0.00 0.00 0.00
Working Capital Turnover Ratio
 0.12 0.14 0.00 0.00 0.00
Cash Conversion Cycle
 524.49 472.01 0.00 61.56 0.00
Days of Sales Outstanding
 177.80 180.90 0.00 0.00 0.00
Days of Inventory Outstanding
 368.65 309.56 0.00 61.56 0.00
Days of Payables Outstanding
 21.97 18.45 0.00 0.00 0.00
Operating Cycle
 546.46 490.46 0.00 61.56 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.25 -0.27 -0.49 -0.20 -0.58
Free Cash Flow Per Share
 -0.28 -0.30 -0.68 -0.27 -0.70
CapEx Per Share
 0.03 0.03 0.19 0.07 0.12
Free Cash Flow to Operating Cash Flow
 1.13 1.11 1.39 1.36 1.21
Dividend Paid and CapEx Coverage Ratio
 -7.96 -8.80 -2.54 -2.77 -4.68
Capital Expenditure Coverage Ratio
 -7.96 -8.80 -2.54 -2.77 -4.68
Operating Cash Flow Coverage Ratio
 -4.55 -5.14 -14.43 -27.83 -7.77
Operating Cash Flow to Sales Ratio
 -1.30 -1.50 0.00 0.00 0.00
Free Cash Flow Yield
-8.65%-5.76%-44.46%-8.85%-13.60%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -10.88 -18.55 -4.26 -3.88 -5.29
Price-to-Sales (P/S) Ratio
 16.94 28.92 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
 1.73 2.91 0.57 1.01 1.42
Price-to-Free Cash Flow (P/FCF) Ratio
 -11.57 -17.36 -2.25 -11.30 -7.36
Price-to-Operating Cash Flow Ratio
 -13.02 -19.33 -3.14 -15.39 -8.93
Price-to-Earnings Growth (PEG) Ratio
 -0.50 0.83 0.09 0.15 0.13
Price-to-Fair Value
 1.73 2.91 0.57 1.01 1.42
Enterprise Value Multiple
 -11.79 -22.76 -4.06 -2.61 -3.23
Enterprise Value
 674.31M 1.19B 180.83M 386.64M 766.63M
EV to EBITDA
 -11.78 -22.76 -4.06 -2.61 -3.23
EV to Sales
 15.14 27.10 0.00 0.00 0.00
EV to Free Cash Flow
 -10.34 -16.27 -1.08 -5.79 -4.49
EV to Operating Cash Flow
 -11.64 -18.12 -1.51 -7.89 -5.45
Tangible Book Value Per Share
 1.45 1.40 1.64 2.02 2.60
Shareholders’ Equity Per Share
 1.85 1.79 2.71 3.07 3.63
Tax and Other Ratios
Effective Tax Rate
 0.27 0.29 0.00 -0.03 0.11
Revenue Per Share
 0.19 0.18 0.00 0.00 0.00
Net Income Per Share
 -0.29 -0.28 -0.36 -0.80 -0.98
Tax Burden
 0.73 0.73 0.94 1.03 0.89
Interest Burden
 1.34 1.34 1.53 1.15 1.06
Research & Development to Revenue
 1.35 1.33 0.00 0.00 0.00
SG&A to Revenue
 0.41 0.26 0.00 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 1.38 0.96 1.36 0.28 0.69
Currency in CNY